Alpha 2.0
Login Register
» Authors » Julie M Villanueva

Julie M Villanueva

Explore the profile of Julie M Villanueva including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 1293
Followers 0
Related Specialties
Infectious Diseases
Microbiology
General Medicine
Top 10 Co-Authors
Margaret A Honein
James Stevens
Paul J Carney
Jessie C Chang
Hua Yang
Larisa V Gubareva
Charles T Davis
Jennifer D Thomas
Adam MacNeil
Ruben O Donis
Published In
J Virol
MMWR Morb Mortal Wkly Rep
Emerg Infect Dis
J Infect Dis
PLoS One
Affiliations
Soon will be listed here.
Recent Articles
1.
A Framework for Assessing Viral Pathogens: A Key Element of the BARDA Emerging Infectious Diseases Strategy
White R, Kovacs G, Chandran S, Adams P, Britson K, Cao H, et al.
Health Secur . 2025 Jan; 23(1):47-54. PMID: 39882823
The COVID-19 pandemic has revealed the need for nations to prepare more effectively for emerging infectious diseases. Preparing for these threats requires a multifaceted approach that includes assessing pathogen threat,...
2.
Evaluation of the Laboratory Response Network and Testing Access During the First 10 Weeks of the Mpox Response, United States, May 17-July 31, 2022
Thomas K, Aden T, Blevins P, Raziano A, Wolford T, Honein M, et al.
Public Health Rep . 2024 Aug; :333549241269497. PMID: 39189096
Objectives: The Laboratory Response Network (LRN) consists of US and international laboratories that respond to public health emergencies, such as biothreats. We used a qualitative approach to assess the successes...
3.
Birth Outcomes Related to Prenatal Zika, Dengue, and Other Flavivirus Infections in the Zika en Embarazadas y Niños Prospective Cohort Study in Colombia
Tannis A, Newton S, Rico A, Gonzalez M, Benavides M, Ricaldi J, et al.
Am J Trop Med Hyg . 2024 Jul; 111(3):622-626. PMID: 38981499
Zika virus (ZIKV) infection in pregnancy is associated with severe abnormalities of the brain and eye and other adverse outcomes. Zika en Embarazadas y Niños was a prospective cohort study...
4.
Travel history among persons infected with SARS-CoV-2 variants of concern in the United States, December 2020-February 2021
Dunajcik A, Haire K, Thomas J, Moriarty L, Springer Y, Villanueva J, et al.
PLOS Glob Public Health . 2023 Mar; 3(3):e0001252. PMID: 36989218
The first three SARS-CoV-2 phylogenetic lineages classified as variants of concern (VOCs) in the United States (U.S.) from December 15, 2020 to February 28, 2021, Alpha (B.1.1.7), Beta (B.1.351), and...
5.
Rapid Diagnostic Testing for Response to the Monkeypox Outbreak - Laboratory Response Network, United States, May 17-June 30, 2022
Aden T, Blevins P, York S, Rager S, Balachandran D, Hutson C, et al.
MMWR Morb Mortal Wkly Rep . 2022 Jul; 71(28):904-907. PMID: 35834423
As part of public health preparedness for infectious disease threats, CDC collaborates with other U.S. public health officials to ensure that the Laboratory Response Network (LRN) has diagnostic tools to...
6.
Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations - United States, 2021
Malenfant J, Joyce A, Choi M, Cossaboom C, Whitesell A, Harcourt B, et al.
MMWR Morb Mortal Wkly Rep . 2022 Feb; 71(8):290-292. PMID: 35202354
On December 19, 2019, the Food and Drug Administration (FDA) approved rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO, Merck) for the prevention of Ebola virus disease (EVD) caused by infection with Ebola virus,...
7.
Multistate Outbreak of SARS-CoV-2 Infections, Including Vaccine Breakthrough Infections, Associated with Large Public Gatherings, United States
Gharpure R, Sami S, Vostok J, Johnson H, Hall N, Foreman A, et al.
Emerg Infect Dis . 2021 Nov; 28(1):35-43. PMID: 34793690
During July 2021, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.617.2 variant infections, including vaccine breakthrough infections, occurred after large public gatherings in Provincetown, Massachusetts, USA, prompting a multistate investigation....
8.
Performance Characteristics of the Abbott BinaxNOW SARS-CoV-2 Antigen Test in Comparison to Real-Time Reverse Transcriptase PCR and Viral Culture in Community Testing Sites during November 2020
Almendares O, Prince-Guerra J, Nolen L, Gunn J, Dale A, Buono S, et al.
J Clin Microbiol . 2021 Oct; 60(1):e0174221. PMID: 34705535
Point-of-care antigen tests are an important tool for SARS-CoV-2 detection. Antigen tests are less sensitive than real-time reverse transcriptase PCR (rRT-PCR). Data on the performance of the BinaxNOW antigen test...
9.
Pregnancy, Birth, Infant, and Early Childhood Neurodevelopmental Outcomes among a Cohort of Women with Symptoms of Zika Virus Disease during Pregnancy in Three Surveillance Sites, Project (VEZ), Colombia, 2016-2018
Mercado-Reyes M, Gilboa S, Valencia D, Daza M, Tong V, Galang R, et al.
Trop Med Infect Dis . 2021 Oct; 6(4). PMID: 34698287
Project (VEZ), an intensified surveillance of pregnant women with symptoms of the Zika virus disease (ZVD) in Colombia, aimed to evaluate the relationship between symptoms of ZVD during pregnancy and...
10.
Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites - Pima County, Arizona, November 3-17, 2020
Prince-Guerra J, Almendares O, Nolen L, Gunn J, Dale A, Buono S, et al.
MMWR Morb Mortal Wkly Rep . 2021 Jan; 70(3):100-105. PMID: 33476316
Rapid antigen tests, such as the Abbott BinaxNOW COVID-19 Ag Card (BinaxNOW), offer results more rapidly (approximately 15-30 minutes) and at a lower cost than do highly sensitive nucleic acid...